The European Commission on Friday extended the authorization of the Imvanex mpox vaccine to teenagers aged 12 to 17.

With more than 200 mpox-related deaths reported globally, the EMA has approved Imvanex for adolescents aged 12-17 years.

Experts say a Mpox outbreak in India is likely but caution against panic. Learn about the virus, its symptoms, and how to ...

The European Medicines Agency (EMA) has approved the use of Bavarian Nordic’s mpox vaccine in adolescents, increasing the ...

Bavarian's JYNNEOS has also been approved by the U.S. Food and Drug Administration (FDA) but only for adults 18 years and ...

The first 300 doses were administered on Tuesday near the border with the Democratic Republic of Congo, a spokesperson for ...

The UN Children’s Fund, UNICEF, issued an urgent appeal on Friday for nearly $59 million to support efforts to halt the rapid ...

Mpox, declared a global public health emergency by WHO, has disproportionately affected children and adolescents ...

Health Minister of Indian state of Kerala, Veena George, said on Thursday that genome sequencing will be conducted to ...

Congo's South Kivu province is at the epicenter of the world’s latest mpox outbreak, in what the World Health Organization ...

EU drug regulator approves use of Bavarian Nordic's mpox vaccine, Imvanex for adolescents: Copengagen, Denmark Saturday, September 21, 2024, 10:00 Hrs [IST] Bavarian Nordic A/S, a ...

Rwanda has launched the first mpox vaccination campaign in Africa, marking a significant step in the continent's fight ...